| Round | Date | Amount |
|---|---|---|
| — | 2026-09-29 | $150M |
| — | 2026-09-08 | $3.0B |
| Series C | 2026-09-08 | $150M |
<a href="https://steek.live/companies/3143"><img src="https://api.steek.live/scoreboard/company/3143/badge.svg" alt="Steek Score" width="248" height="64" /></a>| Company | Raised | Score |
|---|---|---|
| Candid Health Candid Health builds automated healthcare revenue cycle management and medical billing software that helps medical groups, digital health companies, and billing teams submit claims, reduce denials, and accelerate insurance reimbursement workflows. | $120M | 63 |
| HealthLeap | $38M | 59 |
| Suki | $90M | 58 |
| October 24 | $211M | 56 |
| October 17 | $328M | 55 |
| XRlabs | $8M | 54 |
| Cent | $15M | 53 |
| October 10 | $116M | 52 |
| OMass Therapeutics | $275M | 52 |
| DropGenie | $5M | 52 |
Forus has a Steek Score of 59 (Emerging) — a transparent 0–100 momentum index built from funding, traction and attention signals.
Forus operates in healthcare ai, where it ranks #2 of 67 by Steek Score.
Forus has raised $3.0B, most recently a Series C round (2026-09-29).
Top competitors include Candid Health, HealthLeap, Suki.
Steek Score is a transparent momentum index computed from tracked public signals. Not investment advice.